insights_auto
Outlook: 46.7% bullish·0.0% bearish
Go to analysischevron_right
BDX:NYSE
Becton Dickinson and Co
$183.75
arrow_upward
+0.55%(+1.00) 1D
Oct 9, 4:00:02 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BDX...
Open
$181.89
High
$183.85
Low
$181.51
Mkt. cap
50.05B
Avg. vol.
1.79M
Volume
2.00
Dividend
2.29%
Quarterly dividend
$1.05
Ex-dividend date
Sep 9, 2026
P/E ratio
55.51
52-wk high
$193.07
52-wk low
$127.54
EPS
$3.31
Beta
0.21
Shares outstanding
272.39M
No. of employees
72K
Open
$181.89
High
$183.85
Low
$181.51
Mkt. cap
50.05B
Avg. vol.
1.79M
Volume
2.00
Dividend
2.29%
Quarterly dividend
$1.05
Ex-dividend date
Sep 9, 2026
P/E ratio
55.51
52-wk high
$193.07
52-wk low
$127.54
EPS
$3.31
Beta
0.21
Shares outstanding
272.39M
No. of employees
72K
News stories
From web sources and news partners
Profile
Becton, Dickinson and Company is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain areas.
BD is ranked #211 in the 2024 Fortune 500 list based on its revenues for the fiscal year ending September 30, 2023. Wikipedia
About Becton Dickinson and Co
CEOThomas Polen
Employees72K
Founded1897
HeadquartersFranklin Lakes, New Jersey, United States
SectorMedical device
Websitebd.com